angiotensin ii has been researched along with labetalol in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (58.33) | 18.7374 |
| 1990's | 9 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, JJ; Fraser, R; Lever, AF; Morton, JJ; Robertson, JI; Rosei, EA; Trust, PM | 3 |
| Gifford, RW; Tarazi, RC; Wollam, GL | 1 |
| Avery, GS; Brogden, RN; Heel, RC; Speight, TM | 1 |
| Hayduk, K | 1 |
| Andréjak, M; Bataille, P; Fournier, A; Gheerbrant, JD; Hardin, JM; Makdassi, R | 1 |
| Brown, JJ; Cumming, AM; Lever, AF; Mackay, A; Robertson, JI | 1 |
| Brown, JJ; Cummings, AM; Fraser, R; Lever, AF; Morton, JJ; Richards, DA; Robertson, JI | 1 |
| Johnston, CI; Matthews, PG; Maydom, BW; McGrath, BP; Walter, NM | 1 |
| Graham, BR; Prichard, BN; Tomlinson, B; Walden, RJ | 1 |
| Allen, J; Forman, A; Maigaard, S; Skajaa, K | 1 |
| Colindres, RE; Cubeddu, LX; Fuenmayor, N; Powell, JR; Varin, F; Villagra, VG | 2 |
| Bompart, F; Graham, BR; Liu, JB; Prichard, BN; Tomlinson, B | 1 |
| Corvol, P; Lardoux, H; Martinand, A; Milliez, P | 1 |
| Abassi, ZA; Cuda, G; Golomb, E; Keiser, HR; Panchal, VR; Stylianou, M; Trachewsky, D | 1 |
| Bartels, GL; de Leeuw, PW; Kruijssen, HA; Remme, WJ; von Schelven, D | 1 |
| Blaschke, TF; Haefeli, WE; Hoffman, BB; Kongpatanakul, S; Srivastava, N | 1 |
| Andersson, B; Eriksson, S; Gunnarsson, U; Rundgren, M | 1 |
| Larsen, FS; Olsen, KS; Svendsen, LB | 1 |
| Guy, S; McKaigue, JP; Riddell, JG; Shanks, RG; Tham, TC | 1 |
| Bowes, MP; Fagan, SC; Lyden, PD; Zivin, JA | 1 |
| Cervenka, L; Chábová, VČ; Husková, Z; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Malý, J; Netuka, I; Opočenský, M; Rakušan, D; Sadowski, J; Schejbalová, S; Skaroupková, P; Vaněčková, I; Vaňourková, Z; Vernerová, Z; Walkowska, A | 1 |
3 review(s) available for angiotensin ii and labetalol
| Article | Year |
|---|---|
Antihypertensive drugs: clinical pharmacology and therapeutic use.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clonidine; Diazoxide; Diuretics; Ganglionic Blockers; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Minoxidil; Monoamine Oxidase Inhibitors; Nitroprusside; Potassium; Prazosin; Secologanin Tryptamine Alkaloids; Sympatholytics | 1977 |
Labetalol: a review of its pharmacology and therapeutic use in hypertension.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Ethanolamines; Half-Life; Hemodynamics; Humans; Hypertension; Labetalol; Pheochromocytoma; Renin; Respiration | 1978 |
[New antihypertensive agents].
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chemical Phenomena; Chemistry; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Labetalol; Minoxidil; Prazosin | 1979 |
7 trial(s) available for angiotensin ii and labetalol
| Article | Year |
|---|---|
Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Clinical Trials as Topic; Ethanolamines; Heart Rate; Humans; Hypertension; Injections, Intravenous; Labetalol; Propranolol | 1976 |
Effects of intravenous labetalol on blood pressure, angiotensin II and aldosterone in hypertension: comparison with propranolol.
Topics: Aldosterone; Angiotensin II; Depression, Chemical; Ethanolamines; Heart Rate; Humans; Hypertension; Labetalol; Propranolol | 1976 |
Clinical pharmacology of carvedilol.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Double-Blind Method; Hemodynamics; Humans; Labetalol; Male; Norepinephrine; Phenylephrine; Propanolamines; Vasodilator Agents | 1992 |
Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Blood Pressure; Carbazoles; Carvedilol; Half-Life; Heart Rate; Humans; Isoproterenol; Labetalol; Phenylephrine; Propanolamines; Random Allocation; Vasodilation | 1987 |
Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Cold Temperature; Double-Blind Method; Exercise; Heart Rate; Hemodynamics; Humans; Hydralazine; Isoproterenol; Labetalol; Male; Middle Aged; Phenylephrine; Posture; Propanolamines; Propranolol; Vasodilator Agents | 1988 |
Clinical pharmacology of carvedilol in normal volunteers.
Topics: Adult; Angiotensin II; Blood Pressure; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Heart Rate; Humans; Isoproterenol; Kinetics; Labetalol; Male; Phenylephrine; Propanolamines; Random Allocation; Receptors, Adrenergic | 1987 |
The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adult; Angiotensin II; Blood Pressure; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Exercise; Fingers; Heart Rate; Humans; Labetalol; Male; Phenylephrine; Systole; Tremor; Vasoconstrictor Agents; Vasodilator Agents | 1993 |
14 other study(ies) available for angiotensin ii and labetalol
| Article | Year |
|---|---|
Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aldosterone; Angiotensin II; Clonidine; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Pheochromocytoma; Propranolol; Substance Withdrawal Syndrome | 1976 |
[Clinical pharacology of the new antihypertensive drugs: renin-angiotensin system antagonists, recent vasodilators and dopaminergic agonists].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Dopamine Antagonists; Humans; Labetalol; Minoxidil; Nifedipine; Prazosin; Renin; Saralasin; Tetrahydronaphthalenes; Vasodilator Agents | 1979 |
Treatment of severe hypertension by repeated bolus injections of labetalol.
Topics: Adolescent; Adult; Aged; Angiotensin II; Blood Pressure; Creatinine; Ethanolamines; Female; Humans; Hypertension; Hypertension, Malignant; Injections, Intravenous; Labetalol; Male; Middle Aged; Renin | 1979 |
Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Infusions, Parenteral; Labetalol; Middle Aged; Time Factors | 1979 |
Emergency treatment of severe hypertension with intravenous labetalol.
Topics: Adult; Aged; Angiotensin II; Emergencies; Ethanolamines; Female; Humans; Hypertension; Infusions, Parenteral; Labetalol; Male; Middle Aged; Pulse; Renin | 1978 |
Effects of vasodilators on isolated human uteroplacental arteries.
Topics: Angiotensin II; Arteries; Chorionic Villi; Dinoprost; Female; Humans; Hydralazine; Labetalol; Nitrendipine; Norepinephrine; Potassium; Prazosin; Pregnancy; Uterus; Vasoconstriction; Vasodilator Agents; Vasopressins | 1991 |
[Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
Topics: Adult; Angiotensin II; Blood Pressure; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Renin | 1980 |
Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats.
Topics: Actins; Angiotensin II; Animals; Base Sequence; Biphenyl Compounds; Blood Pressure; Captopril; Cardiomegaly; DNA; DNA Primers; Dose-Response Relationship, Drug; Gene Expression; Genes, fos; Heart; Hydralazine; Hydroxyproline; Imidazoles; Isoproterenol; Labetalol; Losartan; Male; Methyldopa; Molecular Sequence Data; Myocardium; Myosins; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA; RNA, Messenger; Tetrazoles; Transcription, Genetic | 1994 |
Acute hemodynamic and neurohumoral profile of dilevalol in hypertensive patients with ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II; Cardiac Catheterization; Dopamine; Epinephrine; Female; Hemodynamics; Humans; Hypertension; Labetalol; Male; Middle Aged; Myocardial Ischemia; Myocardium; Neurotransmitter Agents; Norepinephrine; Oxygen Consumption; Renin | 1993 |
Lack of role of endothelium-derived relaxing factor in effects of alpha-adrenergic agonists in cutaneous veins in humans.
Topics: Adrenergic alpha-Agonists; Adult; Angiotensin II; Bradykinin; Cyclic GMP; Dose-Response Relationship, Drug; Female; Hand; Humans; Labetalol; Male; Methylene Blue; Nitric Oxide; Skin; Vasoconstriction; Veins | 1993 |
Hypertension and thirst outlasting renal vasoconstriction as effects of a brief evaluation of systemic angiotensin II in sheep.
Topics: Angiotensin II; Animals; Blood Pressure; Female; Hypertension; Infusions, Intra-Arterial; Infusions, Intravenous; Labetalol; Regional Blood Flow; Renal Artery; Sheep; Thirst; Time Factors; Vasoconstriction | 1994 |
Validation of transcranial near-infrared spectroscopy for evaluation of cerebral blood flow autoregulation.
Topics: Adult; Angiotensin II; Antihypertensive Agents; Blood Pressure; Brain; Cerebrovascular Circulation; Female; Hemoglobins; Homeostasis; Humans; Jugular Veins; Labetalol; Lower Body Negative Pressure; Male; Oximetry; Oxygen; Oxygen Consumption; Radial Artery; Reproducibility of Results; Spectroscopy, Near-Infrared; Vasoconstrictor Agents | 1996 |
Acute hypertension promotes hemorrhagic transformation in a rabbit embolic stroke model: effect of labetalol.
Topics: Acute Disease; Angiotensin II; Animals; Antihypertensive Agents; Cerebral Hemorrhage; Cerebral Infarction; Hypertension; Intracranial Embolism and Thrombosis; Labetalol; Male; Rabbits | 1998 |
Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Creatinine; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Furosemide; Hydrochlorothiazide; Hypertension; Indoles; Kidney Failure, Chronic; Labetalol; Losartan; Proteinuria; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System | 2010 |